Home›Oncology› Empowered Survivor digital tool boosts self-efficacy in oral cancer survivors
Empowered Survivor digital tool boosts self-efficacy in oral cancer survivorsDigital Intervention Improves Self-Care for Oral Cancer Survivors
Psycho-oncologyPublished September 10, 2026Study authors: Manne Sharon L, Hudson Shawna V, Van Cleave Janet H, Grosso Marissa, Frederick Sara, Pesanelli Morga…PubMed ↗NCT04713449 ↗DOI ↗Editorial oversight: Dr. Julia Lee, PhD · Oncology, Genomics & Drug Development
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider digital self-management tools to support self-efficacy in oral cancer survivors, but note limited outcome data.
This randomized controlled trial evaluated the Empowered Survivor (ES) digital intervention against a Generic Online Intervention (GO) in 643 individuals diagnosed with oral or oropharyngeal cancer within the past 3 years. The trial assessed self-efficacy, survivorship preparedness, health-related quality of life (HRQoL), and self-care activities at 2 and 6 months.
The ES group reported greater self-efficacy than the GO group at both 2 months (p = 0.003) and 6 months (p < 0.001). Self-care activities, including oral self-exams, swallowing, and mobility exercises, also increased in the ES group compared with GO, though p-values were not reported for this outcome. Effect sizes and absolute numbers were not reported.
Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The trial did not report survivorship preparedness or HRQoL results, and the authors note that further examinations of these outcomes are warranted. Funding and conflicts of interest were not reported.
The findings suggest that a tailored digital intervention may enhance self-efficacy and self-care behaviors in this population. However, the lack of effect sizes, safety reporting, and confirmed benefits for preparedness and HRQoL limit definitive conclusions. Clinicians should interpret these patient-reported gains cautiously and await further data before integrating such tools into routine survivorship care.
How this fits prior evidence
This randomized trial extends prior coverage of oral cancer survivorship by testing a digital self-management intervention, a gap not addressed by earlier items on risk factors, diagnostics, or therapeutics. Prior coverage highlighted metabolic syndrome as a risk factor for oral cancer (HR 1.12), hyperspectral imaging for detection, and berberine or EGCG for oral conditions, all focused on prevention or treatment rather than survivorship support. The current finding that Empowered Survivor improved self-efficacy and self-care activities at 2 and 6 months adds patient-centered outcome data to a literature previously dominated by disease-oriented endpoints. It does not confirm or contrast with those prior findings directly, but shifts attention to post-treatment self-management, where evidence remains limited.
Researchers conducted a randomized trial to see how a digital program called Empowered Survivor (ES) affected people with oral or oropharyngeal cancer. The study included 643 people diagnosed within the last three years. They compared this specific program against a generic online intervention to see which one helped patients better.
The results showed that people using the Empowered Survivor program had significantly higher self-efficacy compared to those using the generic version. This improvement was measured at both two months and six months. Additionally, the group using the specialized program performed more self-care activities, including oral self-exams and exercises for swallowing and mobility.
While the results are promising for patient confidence and daily activities, the study notes that more research is needed to fully understand how it affects long-term preparedness and quality of life. This trial suggests the digital tool is a helpful way to support survivors in managing their daily health routines.
What this means for you:
A specialized digital program can improve self-efficacy and self-care activities for oral cancer survivors.
Common questions
What kind of activities did the digital program help with?
The Empowered Survivor program helped patients increase their participation in specific self-care activities. These included oral self-exams, as well as exercises focused on swallowing and mobility. These activities are important for managing daily life after a diagnosis of oral or oropharyngeal cancer.
How did the program affect patient confidence?
Patients who used the Empowered Survivor digital intervention showed significantly higher self-efficacy than those who used a generic online program. This increase in confidence was measured at both the two-month and six-month marks following the start of the intervention.
Who was included in this study?
The study included 643 individuals who had been diagnosed with oral or oropharyngeal cancer within the three years prior to the study. The results specifically show how the digital intervention helped this group of survivors manage their care.
BACKGROUND: Oral and oropharyngeal cancer survivors experience debilitating physical and psychosocial challenges. Little knowledge exists on the efficacy of interventions to enhance self-efficacy in managing these challenges, increase survivorship preparedness, and improve health-related quality of life (HRQoL).
METHODS: Individuals (n = 643) diagnosed with oral or oropharyngeal cancer diagnosed within past 3 years were randomized to a digital intervention, Empowered Survivor (ES) or a Generic Online Intervention (GO). Primary (self-efficacy, preparedness, HRQoL) and secondary outcomes (self-care activities) were measured at Baseline, 2-months, and 6-months.
RESULTS: Participants assigned to ES reported greater self-efficacy and increased self-care activities of oral self-exams, swallowing, and mobility exercises than those assigned to GO (self-efficacy: 2 months, p = 0.003, 6-months, p < 0.001; self-care activities).
CONCLUSIONS: The ES enhanced self-efficacy and increased self-care activities. Further examinations of survivorship preparedness and HRQoL in oral and oropharyngeal cancer are warranted.
TRIAL REGISTRATION: Registered on clinicaltrials. gov as NCT04713449.
